New Standard of Care for Metastatic Renal Cell Carcinoma

Share this post

Combination treatment with pembrolizumab and axitinib significantly improved survival outcomes as compared with sunitinib.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply